The Office of Medical Technology Transfer at Fort Detrick, Maryland, has been recognized for its success in commercializing innovative life-saving devices and medicines for the Warfighter and the public. Chief of business development and commercialization, Barry Datlof, recently received the Department of Defense George F. Linsteadt Technology Transfer Achievement Award for developing and implementing the Assistive Technology Transfer (AT2) program. The AT2 program has helped license over 30 biomedical technologies, generating over $26 million in royalty income. This success has enabled MTT to reinvest in new inventions and create a feedback loop of success.
Datlof credits the success of the program to a team of experts who are willing to take risks and think creatively. He emphasizes the importance of purpose in technology transfer and recognizes the collaborative effort of the entire MTT team in achieving success. Looking ahead, Datlof proposes the establishment of a DOD-wide “angel fund” to accelerate the adoption of AT2 at smaller tech transfer offices. He also plans to leverage digital marketplace technologies to facilitate technology transfer and expand international patent portfolios to increase licensee income streams.
Overall, the Office of Medical Technology Transfer’s approach to technology transfer has been recognized as innovative and successful, with a focus on saving lives and benefiting both military and civilian applications. With a strong team and a commitment to purpose-driven work, the MTT office is poised for continued success in the field of medical technology transfer.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
